Prot #KT‐US‐471‐0140: Expanded Access Study for the Treatment of Patients with Commercially Out‐of‐Specification Axicabtagene Ciloleuce

Project: Research project

Project Details

StatusActive
Effective start/end date9/14/239/14/26

Funding

  • ICON Clinical Research Limited (Prot #KT-US-471-0140 // Prot #KT-US-471-0140)
  • Kite Pharma, Inc. (Prot #KT-US-471-0140 // Prot #KT-US-471-0140)